Jean-Antoine Ribeil PhD

Associate Professor, Hematology & Oncology

820 Harrison Ave | (617) 638-7011
Antoine-Jean Ribeil


BU Profile



Medicine, MD, Univ of Aix Marseille, 1995

Cell & Molecular Biology, PhD, University of Paris Vii, 2010


Published on 6/13/2023

Hara Y, Lemgart VT, Halland N, Mahdaviani K, Ribeil JA, Lessard S, Hicks A, Light DR. SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells. Blood Adv. 2023 Jun 13; 7(11):2317-2323. PMID: 36696461.

Published on 5/12/2023

Ribeil JA, Pollock G, Frangoul H, Steinberg MH. An integrated therapeutic approach to sickle cell disease management beyond infancy. Am J Hematol. 2023 May 12. PMID: 37170801.

Published on 10/10/2022

Kanter J, Thompson AA, Pierciey FJ, Hsieh M, Uchida N, Leboulch P, Schmidt M, Bonner M, Guo R, Miller A, Ribeil JA, Davidson D, Asmal M, Walters MC, Tisdale JF. Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study. Am J Hematol. 2023 Jan; 98(1):11-22. PMID: 36161320.

Published on 1/24/2022

Magrin E, Semeraro M, Hebert N, Joseph L, Magnani A, Chalumeau A, Gabrion A, Roudaut C, Marouene J, Lefrere F, Diana JS, Denis A, Neven B, Funck-Brentano I, Negre O, Renolleau S, Brousse V, Kiger L, Touzot F, Poirot C, Bourget P, El Nemer W, Blanche S, Tréluyer JM, Asmal M, Walls C, Beuzard Y, Schmidt M, Hacein-Bey-Abina S, Asnafi V, Guichard I, Poirée M, Monpoux F, Touraine P, Brouzes C, de Montalembert M, Payen E, Six E, Ribeil JA, Miccio A, Bartolucci P, Leboulch P, Cavazzana M. Long-term outcomes of lentiviral gene therapy for the ß-hemoglobinopathies: the HGB-205 trial. Nat Med. 2022 01; 28(1):81-88. PMID: 35075288.

Published on 12/12/2021

Kanter J, Walters MC, Krishnamurti L, Mapara MY, Kwiatkowski JL, Rifkin-Zenenberg S, Aygun B, Kasow KA, Pierciey FJ, Bonner M, Miller A, Zhang X, Lynch J, Kim D, Ribeil JA, Asmal M, Goyal S, Thompson AA, Tisdale JF. Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. N Engl J Med. 2022 02 17; 386(7):617-628. PMID: 34898139.

Published on 10/20/2021

Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F, Lucchini MJ, Machin J, Nimubona S, Ribeil JA, Galacteros F, Cannas G, Hot A. Pregnancy outcome in women with transfused beta-thalassemia in France. Ann Hematol. 2022 Feb; 101(2):289-296. PMID: 34668980.

Published on 10/19/2021

Ribeil JA. Primary myelofibrosis in untreated sickle cell disease: Are adult patients at higher risk for developing hematological myeloid neoplasms? Am J Hematol. 2022 01 01; 97(1):4-6. PMID: 34626435.

Published on 3/24/2021

Chauvet M, Chhuon C, Lipecka J, Dechavanne S, Dechavanne C, Lohezic M, Ortalli M, Pineau D, Ribeil JA, Manceau S, Le Van Kim C, Luty AJF, Migot-Nabias F, Azouzi S, Guerrera IC, Merckx A. Sickle Cell Trait Modulates the Proteome and Phosphoproteome of Plasmodium falciparum-Infected Erythrocytes. Front Cell Infect Microbiol. 2021; 11:637604. PMID: 33842387.

Published on 2/11/2021

Joseph L, Jean C, Manceau S, Chalas C, Arnaud C, Kamdem A, Pondarré C, Habibi A, Bernaudin F, Allali S, de Montalembert M, Boutonnat-Faucher B, Arlet JB, Koehl B, Cavazzana M, Ribeil JA, Lionnet F, Berthaut I, Brousse V. Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease. Blood. 2021 02 11; 137(6):826-829. PMID: 32976551.

Published on 6/3/2020

Tisdale JF, Pierciey FJ, Bonner M, Thompson AA, Krishnamurti L, Mapara MY, Kwiatkowski JL, Shestopalov I, Ribeil JA, Huang W, Asmal M, Kanter J, Walters MC. Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial. Am J Hematol. 2020 09; 95(9):E239-E242. PMID: 32401372.

View full list of 69 publications.